Clinical-epidemiological profile of patients infected by COVID-19 in a municipality in southern Brazil
DOI:
https://doi.org/10.33448/rsd-v12i5.41552Keywords:
Incidence; Collective Health; COVID-19; Mortality.Abstract
Objective: This study aims to identify the clinical-epidemiological profile of patients infected by COVID-19 in a municipality in southern Brazil from 2020 to 2022. Method: This is an observational, cross-sectional, retrospective, descriptive, quantitative study carried out with individuals infected with SARS-CoV-2 with notification registered in the database of a health service in the south of Santa Catarina. This infection is confirmed through laboratory tests (RT-PCR and/or antigen testing). Results: Females were the most affected (54.4%), the mean age was 42.21 years, with the most prevalent age group being 30-39 years (25.9%). The most used drug was azithromycin (13.2%). 27% had some pre-existing comorbidity, with systemic arterial hypertension being the underlying condition with the highest percentage (12.4%). The most prevalent symptoms were headache (47.1%), myalgia (43.9%) and cough (43.8%). 7.8% required hospitalization, 2.2% required the Intensive Care Unit, 98.4% were cured and 1.6% died. Conclusion: In the present study, the majority of COVID-19 infected patients were female, aged between 30-39 years. Males with preexisting comorbidities, within the age group 50-59 years, were more prevalent among those hospitalized, admission to the Intensive Care Unit and deaths.
References
Berlin, D. A., Gulick, R. M. & Martinez, F. J. (2020). Severe Covid-19. N Engl J Med., 383(25), 2451–60.
Brasil. (2019). Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Ministério da Saúde.
Brasil. (2021). Centro de Operações de Emergência em Saúde Pública. Bol Epidemiol Diário.
Brasil. (2021). Informe Semanal n° 37 de Evidências sobre Variantes de Atenção de SARS-CoV-2, 112.
Cavalcante, J. R., & Abreu, A. D. J. L. D. (2020). COVID-19 no município do Rio de Janeiro: análise espacial da ocorrência dos primeiros casos e óbitos confirmados. Epidemiologia e Serviços de Saúde, 29, e2020204.
Centers for Disease Control and Prevention. (2020). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19).
CEPAL, N. (2020). Latin America and the Caribbean and the COVID-19 pandemic: economic and social effects. COVID-19 Special Report., 1-13.
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D. et al. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England. Science, 372(6538), eabg3055.
Dourado, P., Ricco, T., & Vieira, L. (2021). Variante ômicron. Subsecretaria de Saúde Gerência de Informações Estratégicas em Saúde CONECTA-SUS, 1-8.
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R. et al. (2020). Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. Morbidity and mortality weekly report, 69(15), 458.
Giovanetti, M., Fonseca, V., Wilkinson, E., Tegally, H., San, E. J., Althaus, C. L. et al. (2022). Replacement of the Gamma by the Delta variant in Brazil: Impact of lineage displacement on the ongoing pandemic. Virus evolution, 8(1), veac024, 1–6.
Grint, D. J., Wing, K., Williamson, E., McDonald, H. I., Bhaskaran, K., Evans, D. et al. (2021). Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February. Eurosurveillance, 26(11), 2100256.
Heidary, F., & Gharebaghi, R. (2020). Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. The Journal of antibiotics, 73(9), 593-602.
Heymann, D. L., & Shindo, N. (2020). COVID-19: what is next for public health? The lancet, 395(10224), 542-545.
Hochman, B., Nahas, F. X., Filho, R. S. de O., & Ferreira, L. M. (2005). Desenhos de pesquisa. Acta Cirúrgica Brasileira, 20, 02–9.
Kass, D. A., Duggal, P., & Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. The Lancet, 395(10236), 1544-1545.
Khan, M., Adil, S. F., Alkhathlan, H. Z., Tahir, M. N., Saif, S., Khan, M., & Khan, S. T. (2021). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26(1), 39.
Kompaniyets, L., Pennington, A. F., Goodman, A. B., Rosenblum, H. G., Belay, B., Ko, J. Y. et al. (2021). Peer Reviewed: Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021. Preventing chronic disease, 18, 1-13.
Li, L. Q., Huang, T., Wang, Y. Q., Wang, Z. P., Liang, Y., Huang, T. B., & Wang, Y. (2020). COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis. Journal of medical virology, 92(6), 577-583.
Liu, J. & Liu, S. (2020). The management of coronavirus disease 2019. Journal of Medical Virology., 92(9), 1484-90.
Mcgonagle, D. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company‘s public news and information.
Nonaka, C. K. V., Gräf, T., de Lorenzo Barcia, C. A., Costa, V. F., de Oliveira, J. L., da Hora Passos, R. et al. (2021). SARS-CoV-2 variant of concern P. 1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021. International Journal of Infectious Diseases, 111, 47-54.
Organização Pan-Americana da Saúde. (2020). Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection. https://iris.paho.org/handle/10665.2/52458
Patone, M., Thomas, K., Hatch, R., Tan, P. S., Coupland, C., Liao, W. et al. (2021). Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases. MedRxiv, 2021-03.
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnell, L., Chernyak, Y. et al. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj, 369.
Prado, P. R. D., Gimenes, F. R. E., Lima, M. V. M. D., Prado, V. B. D., Soares, C. P., & Amaral, T. L. M. (2021). Fatores de risco para óbito por COVID-19 no Acre, 2020: coorte retrospectiva. Epidemiologia e Serviços de Saúde, 30, e2020676.
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W. et al. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama, 323(20), 2052-2059.
Shouman, W. (2020). Prophylactic Ivermectin in COVID‐19 Contacts. ClinicalTrials. gov.
Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., El Burai, F. S. et al. (2020). Coronavirus Disease 2019 Case Surveillance. MMWR Morb Mortal Wkly Rep., 69(24), 759–65.
Suleyman, G., Fadel, R. A., Malette, K. M., Hammond, C., Abdulla, H., Entz, A. et al. (2020). Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA network open, 3(6), e2012270-e2012270.
UpToDate. (2023). COVID-19: Questions and answers. https://www.uptodate.com/contents/covid-19-questions-and-answers
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rafael Tortato Fernandes; Iuri Arent Wensing; Chaiana Esmeraldino Mendes Marcon; Thaelis Tortato Fernandes; Fernanda Souza Schiefler Lopes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
